The math is brutal. The U.S. Fish and Wildlife Service currently protects 1,662 domestic and 638 foreign species under the Endangered Species Act. That list has tripled since 1985.
Federal funding has not tripled. The result: resources per protected species have been roughly cut in half.
Now the government is turning to a startup best known for trying to bring back the woolly mammoth. Colossal Biosciences, through its newly created nonprofit Colossal Foundation, has pledged to collect, sequence, and store genetic material from more than 2,300 threatened and endangered species. The project will be housed across Colossal’s distributed BioVault network.
It will preserve cryopreserved DNA, tissues, and reproductive cells alongside digitized reference genomes for each species. The financial backing for the foundation comes from Colossal’s broader private capital.
The foundation itself is newly erected. The figure attached to it: $1. That is not a typo.
Fish and Wildlife Service director Brian Nesvik was measured in his statement. “This collaboration will help advance our understanding of how biobanking and genomics can complement existing conservation tools,” Nesvik said. Colossal’s chief animal officer Matt James was not measured.
“This initiative will redefine conservation in the United States,” James said. “For the first time, we’re creating a permanent genetic record of America’s most vulnerable species before they’re lost.” That line matters.
“Before they’re lost.” The project is a bet that the current system is failing, and that a genetic backup is the only honest hedge against extinction. The Endangered Species Act has been the primary tool for 52 years. It has saved species.
The bald eagle, the gray wolf, the American alligator. But the list keeps growing.
The funding does not. The Colossal Foundation is not proposing to replace that system. It is proposing to supplement it with something permanent.
A DNA Noah’s Ark. A vault of biological information that can be used now for research and, potentially, later for restoration. If a species goes extinct in the wild, its genetic blueprint remains.
That is not a small thing. Critics might ask whether the money would be better spent on habitat protection or anti-poaching efforts.
That is a fair question. But the project is not zero-sum. The foundation is private money.
The Fish and Wildlife Service is contributing expertise and access. No federal conservation dollars are being diverted.
The scope is staggering. 2,300 species. Each one needs its DNA sequenced, its tissues frozen, its reproductive cells banked. That is a logistics problem on a national scale.
Colossal’s BioVault network is distributed, meaning samples will be stored in multiple locations. Redundancy is the point. A single freezer failure cannot wipe out the collection.
What happens to the data is another question. Reference genomes are digitized.
That means they can be shared, analyzed, and compared. Researchers anywhere can study the genetic diversity of a species without ever touching a live animal. That alone could advance conservation biology in ways that are hard to predict.
The project is new. The foundation is new.
The partnership is new. There are no results yet. There is only a plan and a commitment.
But the plan is specific. The commitment is funded. And the need is not in dispute.
The list of endangered species is 2,300 long and getting longer. The resources are half what they were.
Something had to change. This is that change. Whether it works is another story.
